Search results
DR. DOUGLAS WOLF APPOINTED TO CROHN'S AND COLITIS FOUNDATION'S NATIONAL BOARD OF TRUSTEES
WKBN 27 Youngstown· 1 day agoDr. Wolf's career spans four decades, during which he has dedicated...
Gut instinct: How the microbiome became the wellness obsession du jour
Cosmo via Yahoo News· 6 hours agoMedical experts aren’t certain on why this is, but among the key factors that can contribute to gut...
A bicycle donation to this Brighton nonprofit can change a life
Livingston Daily | Daily Press & Argus via Yahoo News· 4 days agoRepair and Training Center and formalized a training program for mechanics and volunteers. Grants...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 3 days ago...developing therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases, today announced that four scientific abstracts on its lead drug candidate, obefazimod, for the treatment of moderately to severely active ...
5 Surprising Benefits of Taking a Turmeric Supplement Every Day
Best Life· 2 days agoIf you've started seeing turmeric supplements in every health food store and pharmacy, that's...
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 day agoVanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q1 2024 Earnings Call Transcript May 8, 2024 Vanda...
Earnings call: Nektar Therapeutics optimistic on REZPEG and pipeline progress By Investing.com
Investing.com· 6 hours agoNektar Therapeutics (NASDAQ:NKTR) reported a productive first quarter of 2024, focusing on their...
Spyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
The Pilot News· 1 day agoIBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders: ulcerative colitis ("UC") and ...
Veterans exposed to toxins deserve better
Real Change News· 3 days agoToxic exposure at military bases has been overlooked for decades, but it can result in serious, often life-threatening illnesses for veterans. Over 700...
Takeda culls cancer, gut and inflammation drugs in R&D rethink
FierceBiotech· 2 days agoTakeda has made some cuts to its clinical-phase pipeline, hacking off midphase programs and early-stage prospects as part of a push to focus on its most promising candidates. TAK-007 was shaken ...
